Irritable Bowel Syndrome

An investigational, bimodal release ondansetron tablet improved stool consistency in patients with diarrhea-predominant irritable bowel syndrome, according to study results.

Minesapride, an agonist of 5-hydroxytryptamine 4 receptor, was safe and well-tolerated among patients with constipation-predominant irritable bowel syndrome, according to study results.

Antibiotic exposure within 14 days after a screening colonoscopy correlated with an increased chance of subsequent irritable bowel syndrome, according to data from Digestive Disease Week.

In this exclusive video, Gregory Sayuk, MD, MPH, from the division of gastroenterology at Washington University School of Medicine in St. Louis discusses his poster from Digestive Disease Week on four randomized trials that explored the efficacy of Trulance in patients with chronic idiopathic constipation and constipation-predominant irritable bowel syndrome.

In this exclusive video, Gregory S. Sayuk, MD, MPH, of the division of gastroenterology at Washington University School of Medicine in St. Louis, discusses how providers and patients have adapted to changes implemented in gastroenterology practices in response to the COVID-19 pandemic.

A device that can be mounted on an everyday toilet could be used to help detect multiple diseases, including certain cancers, chronic kidney disease and irritable bowel syndrome, according to research published in Nature Biomedical Engineering.

A recent study revealed a correlation between endometriosis and irritable bowel syndrome among adolescents and women with and without endometriosis.

In this exclusive video perspective from the GUILD Conference 2020, Lin Chang, MD, from the David Geffen School of Medicine at the University of California, Los Angeles, discusses her presentation on updates in irritable bowel syndrome.

Factors like reduced disease severity and lower depression scores were associated with better satisfaction scores among patients with irritable bowel syndrome, according to study results.

Many patients with chronic constipation or constipation-predominant irritable bowel syndrome are dissatisfied with their current medications, according to study results.